• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/15 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/15

Total number of patents in this class: 292

10-year publication summary

25
27
35
19
27
24
21
28
32
10
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
The Board of Trustees of the University of Illinois
2623
13
Tetraphase Pharmaceuticals, Inc.
53
9
The Board of Regents of the University of Texas System
2043
8
Novartis AG
11238
6
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1338
6
Dicerna Pharmaceuticals, Inc.
278
5
Pharmatrophix, Inc.
22
5
University of Tennessee Research Foundation
727
5
Kezar Life Sciences
28
5
Janssen Pharmaceutica N.V.
3839
4
President and Fellows of Harvard College
5792
4
Contemporary Amperex Technology Co., Limited
5805
4
West China Hospital, Sichuan University
170
4
BASF SE
19740
3
Massachusetts Institute of Technology
9795
3
JSR Corporation
2476
3
Canopy Growth Corporation
270
3
The Cooper Health System
32
3
SRI International
974
3
Tpat IP LLC
23
3
Other owners 193